share

Ethyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate CAS NO 223711-74-8


Unit Price:

CAS No.:223711-74-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Ethyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate is a high-purity, advanced pharmaceutical intermediate with a distinct quinoxaline core structure. This compound is valued for its role as a critical building block in the synthesis of complex molecules, particularly in medicinal chemistry research and development. It is primarily sought by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and specialty chemical industries for creating novel active ingredients.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of potential drug candidates, particularly those targeting central nervous system (CNS) disorders, oncology, and infectious diseases.
  • Medicinal Chemistry Research: Used extensively in hit-to-lead and lead optimization campaigns to explore structure-activity relationships (SAR) due to its versatile bromo and ester functional groups.
  • Agrochemical Development: Serves as a building block for novel fungicides, herbicides, and insecticides, leveraging the bioactivity of the quinoxaline scaffold.
  • Organic Synthesis Reagent: Employed in cross-coupling reactions (e.g., Suzuki, Buchwald-Hartwig) and other transformations to construct complex heterocyclic systems.
  • Chemical Reference Standard: Used as an analytical standard in quality control laboratories for method development and validation in API manufacturing.

Basic Information

Product Name Ethyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate
CAS No. 223711-74-8
Molecular Formula C₁₁H₉BrN₂O₃
Molecular Weight 297.11 g/mol
Synonyms 7-Bromo-3-oxo-3,4-dihydroquinoxaline-2-carboxylic acid ethyl ester; Ethyl 7-bromo-3-oxo-1,4-dihydroquinoxaline-2-carboxylate; 2-Quinoxalinecarboxylic acid, 7-bromo-3,4-dihydro-3-oxo-, ethyl ester; 7-Bromo-3-oxo-1,4-dihydro-2-quinoxalinecarboxylic Acid Ethyl Ester; 7-Bromo-3-oxo-3,4-dihydro-2-quinoxalinecarboxylate ethyl ester; EBODQC; 223711-74-8
EINECS Contact for details

Quality Control

Our Ethyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. A Certificate of Analysis (COA) detailing all specifications is provided with each shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.